fbpx
January 20, 2022

Getinge Recalls Vaporizer Sevoflurane Maquet Filling Getinge Recalls Vaporizer Sevoflurane Maquet Filling

The Swedish medical technology company Getinge is issuing a recall of the Vaporizer Sevoflurane Maquet Filling for Flow Family Anesthesia Systems due to risk of chemical […]
January 11, 2022

Medicare Intends to Limit Payment for Controversial Alzheimer’s Drug Medicare Intends to Limit Payment for Controversial Alzheimer’s Drug

Medicare intends to limit coverage of the controversial Alzheimer’s drug, aducanumab (Aduhelm, Biogen) via a special program intended to help assess how well this exorbitantly expensive medication […]
January 10, 2022

Cardiovascular Systems Recalls Wirion Embolic Protection Device Cardiovascular Systems Recalls Wirion Embolic Protection Device

Cardiovascular Systems Inc (CSI) has recalled its Wirion embolic protection device (Wirion) due to complaints that the filter may break during retrieval, according to a notice […]
January 5, 2022

CDC Panel Backs Pfizer Booster Shot for Children 12 and Over CDC Panel Backs Pfizer Booster Shot for Children 12 and Over

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The Centers for Disease Control and Prevention’s (CDC’s) Advisory Committee on Immunization […]
January 5, 2022

CDC Endorses Pfizer Booster Shot for Children 12 and Over CDC Endorses Pfizer Booster Shot for Children 12 and Over

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The Centers for Disease Control and Prevention’s (CDC’s) Director Rochelle Walensky, MD, […]
January 4, 2022

FDA Approves Levoketoconazole for Cushing Syndrome FDA Approves Levoketoconazole for Cushing Syndrome

The US Food and Drug Administration has approved levoketoconazole (Recorlev, Xeris Biopharma) for the treatment of endogenous hypercortisolemia in adults with Cushing syndrome for whom surgery […]
December 29, 2021

FDA Approves Lilly’s Insulin Glargine Biosimilar, Rezvoglar FDA Approves Lilly’s Insulin Glargine Biosimilar, Rezvoglar

The US Food and Drug Administration (FDA) has approved Eli Lilly’s biosimilar version of insulin glargine, Rezvoglar KwikPen. The new formulation is the second long-acting glargine […]
December 28, 2021

FDA Approves Tralokinumab for Moderate to Severe AD FDA Approves Tralokinumab for Moderate to Severe AD

The Food and Drug Administration has approved tralokinumab for the treatment of moderate to severe atopic dermatitis (AD) in adults whose disease is not well controlled […]
December 28, 2021

Illness From Breakthrough COVID Often Severe for Cancer Patients Illness From Breakthrough COVID Often Severe for Cancer Patients

Patients with cancer remain vulnerable to breakthrough COVID-19 infection after vaccination and most experience severe outcomes, according to a review of patient data from the international […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0